- Home
- VATE vs CNTB Comparison
VATE vs CNTB Comparison
Compare VATE & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VATE
- CNTB
- Stock Information
- Founded
- VATE 1994
- CNTB 2012
- Country
- VATE United States
- CNTB United States
- Employees
- VATE 4024
- CNTB N/A
- Industry
- VATE Metal Fabrications
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- VATE Industrials
- CNTB Health Care
- Exchange
- VATE Nasdaq
- CNTB Nasdaq
- Market Cap
- VATE 82.6M
- CNTB 68.5M
- IPO Year
- VATE 1996
- CNTB 2021
- Fundamental
- Price
- VATE $6.10
- CNTB $1.17
- Analyst Decision
- VATE
- CNTB Strong Buy
- Analyst Count
- VATE 0
- CNTB 1
- Target Price
- VATE N/A
- CNTB $8.00
- AVG Volume (30 Days)
- VATE 50.3K
- CNTB 24.6K
- Earning Date
- VATE 11-06-2024
- CNTB 09-05-2024
- Dividend Yield
- VATE N/A
- CNTB N/A
- EPS Growth
- VATE N/A
- CNTB N/A
- EPS
- VATE N/A
- CNTB N/A
- Revenue
- VATE $1,364,600,000.00
- CNTB $24,116,000.00
- Revenue This Year
- VATE N/A
- CNTB N/A
- Revenue Next Year
- VATE N/A
- CNTB $63.90
- P/E Ratio
- VATE N/A
- CNTB N/A
- Revenue Growth
- VATE N/A
- CNTB N/A
- 52 Week Low
- VATE $3.25
- CNTB $0.68
- 52 Week High
- VATE $14.60
- CNTB $2.84
- Technical
- Relative Strength Index (RSI)
- VATE 71.67
- CNTB 44.02
- Support Level
- VATE $6.18
- CNTB $1.18
- Resistance Level
- VATE $6.49
- CNTB $1.26
- Average True Range (ATR)
- VATE 0.43
- CNTB 0.07
- MACD
- VATE 0.05
- CNTB -0.01
- Stochastic Oscillator
- VATE 86.72
- CNTB 13.59
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting stations across the United States.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.